Confusion Over Molnupiravir

Поділитися
Вставка
  • Опубліковано 5 січ 2022
  • Molnupiravir has serious safety concerns, not a part of National Task Force treatment says ICMR DG Balram Bhargava. However, 13 pharma cos got EUA approval in India and Dr. Reddy's & Aurobindo Pharma have already launched the drug. Timsy Jaipuria gets you the chronology as to what happened over the last 2 months, when it comes to how the drug became a part of the treatment globally.

КОМЕНТАРІ • 1

  • @macjr2001
    @macjr2001 2 роки тому +1

    Why the algorithm didn’t pick this video to be at the top of the list when looking up this drug is troublesome to me. People should know about the harms this may cause